Effect of Tocotrienols on Lipid Profile in Rabbits by Shahid, Uzma
Journal of Rawalpindi Medical College (JRMC); 2012;16(1):68-69 
 
 68 
Original Article  
Effect of Tocotrienols on Lipid Profile in Rabbits 
 
Uzma Shahid*, Dilshad Ahmed Khan**, Umbreen Noor* ,Shadab Ahmed Butt***, 
*Department of Anatomy, Wah Medical College, Wah Cantt;**Department of Chemical Pathology &  Endocrinology, Armed 
Forces Institute of Pathology, Rawalpindi;***Department of Anatomy, Army Medical College, Rawalpindi. 
 
 
Abstract 
Background: To evaluate the effect of tocotrienols on 
serum lipids in cholesterol-fed rabbits. 
Methods: In this experimental study, thirty six, male 
New Zealand white rabbits were randomly allocated to 
three equal groups. They were given either normal rabbit 
diet (Group-I); or 2% high cholesterol diet (Group-II); or 
2% high cholesterol diet with tocotrienols 6mg/kg body 
weight/day (Group-III) orally for six weeks. Serum lipid 
profile was analyzed at the start and end of study. 
Results: Baseline levels of serum lipids were not 
statistically different among the three groups (p>0.05). By 
the end of experiment, Group-I showed insignificant 
changes (p>0.05) while Groups-II&III exhibited significant 
increase (p<0.001) in serum levels of total cholesterol, LDL-
C, HDL-C and triglyceride in contrast to their baseline 
levels. However, serum total cholesterol, LDL-C and 
triglyceride levels were 27% (p<0.05), 29% (p<0.05), 13% 
(p>0.05) lower respectively and HDL-C concentrations 
were 4% higher (P>0.05) in tocotrienols-supplemented 
group compared with rabbits using only high cholesterol 
control diet. 
Conclusion: Tocotrienols may be therapeutically 
helpful as cholesterol lowering agents.  
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Introduction 
     Hypercholesterolemia is well known to be the 
unique and sufficient cause for the development of  
coronary artery disease, even if the other known 
hazards are absent. The pooled results of many trials 
using diverse cholesterol-lowering regimens pointed 
out that for each 1 mmol/L decrease in total 
cholesterol level, there was a decline in mortality 
associated with coronary artery disease, by at least 
24.5%.1 
       High blood cholesterol levels and especially the 
retention of LDL fraction in the vessel wall lead to 
oxidative stress. Recent suggestions for lowering the 
blood cholesterol levels are aimed at increasing dietary 
antioxidants.2 Vitamin E comprises four tocopherols 
and four tocotrienols [alpha (α), beta (β), gamma (γ) 
and delta (δ)]. However, only 1% of the entire pubmed 
literature on vitamin E deals with tocotrienols and rest 
of all studies were intended for α-tocopherol. 
Interestingly, tocotrienols emerged more potent 
antioxidants than tocopherols. Dissatisfaction with 
outcomes of the trials testing the hypocholesterolemic 
properties of α-tocopherol can be handled with 
tocotrienols.3 
 
Materials and Methods 
       The study was carried out in the centre for 
research in experimental and applied medicine, Army 
Medical College, Rawalpindi, National University of 
Sciences & Technology Pakistan. Thirty six adult male 
New Zealand white rabbits, weighing 1.5 to 2.5 kg 
were obtained from National Institute of Health, 
Islamabad, Pakistan (NIH). Rabbits were kept 
individually in wire-bottomed cages, at a standard 
temperature of 21 ± 20C with 12 hour light/dark cycle. 
Each animal was given 100 g/day powdered normal 
rabbit diet (NIH). Water was available ad libitum. 
Rabbits were adapted to experimental conditions for 
seven days and then randomly segregated into three 
equal study groups. Group-I was maintained on the 
normal rabbit diet for six weeks. For the same period, 
Group-II&III were given 2% high cholesterol diet [2g 
cholesterol powder (Applichem, Germany) mixed 
with 100g normal rabbit diet /head/day], however, 
animals in group-III were also supplemented with 
annatto tocotrienols [mixture of 90% δ- and 10% γ-
tocotrienol (Kabco, USA) in a dose of 6 mg/kg body 
weight/day orally]. Body weight and blood samples 
were taken as baseline (week 0) and at the end of 
experiment (week 6).  
    Serum cholesterol was measured by cholesterol 
oxidase method, triglyceride was measured by GPO-
POD method, High density (HDL-C) and low density 
lipoprotein cholesterol (LDL-C) were analyzed by 
homogenous enzymatic assays. Coefficient of variation 
of the lipids profile assays was < than 4.7%. For 
comparison between means of initial and final lipid 
profile within each group, paired sample‘t’ test was 
applied. Final 6 week data among all the three groups 
were analyzed by one way ANOVA followed by 
Tukey’s post-hoc test. All the results were considered 
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significant at a P-value less than 0.05. 
 
Results 
       Baseline levels of all the variables were not 
statistically different among the three groups (p>0.05). 
By the end of experiment,Group-I showed 
insignificant changes (p>0.05) while Groups-II&III 
exhibited significant increase (p<0.001) in serum levels 
of total cholesterol, LDL-C, HDL-C and triglyceride in 
contrast to their baseline levels. However, serum total 
cholesterol, LDL-C and triglyceride levels were 27% 
(p<0.05), 29% (p<0.05),13% (p>0.05) lower respectively 
and HDL-C concentrations were 4% higher (p>0.05) in 
tocotrienols-supplemented group compared with 
rabbits using high cholesterol control diet(Table I). 
  
Table I. Comparison of serum lipid profile 
(mmol/l) among three groups 
Parameters Group-I Group-II Group-III 
Total 
Cholesterol    
0 Weeks 2.045 ± 0.102 1.914 ± 0.084 2.015 ± 0.086 
6 Weeks 1.964 ± 0.100 31.478 ± 2.222*
 
#  22.850 ± 1.898
# 
Triglyceride
s    
0 Weeks 0.874 ± 0.037 0.820 ± 0.047 0.900 ± 0.047 
6 Weeks 0.882 ± 0.023* 1.613 ± 0.209#  1.407 ± 0.153# 
LDL-C    
0 Weeks 1.172 ± 0.114 1.085 ± 0.070 1.144 ± 0.073 
6 Weeks 1.087 ± 0.097 27.661 ± 2.276*
 
#  19.536 ± 1.760
#  
HDL-C    
0 Weeks 0.523 ± 0.049 0.454 ± 0.015 0.459± 0.021 
6 Weeks 0.472 ± 0.013* 2.579 ± 0.145#  2.678 ± 0.178#  
Data are mean ± SE. n = 12 per group. * denotes significance (P<0.05) 
when compared to other groups. # denotes significance (P<0.05) 
when compared between 0 & 6 weeks of each group. 
 
Discussion 
   The present study uncovered the effect of 
tocotrienols on serum lipids in New Zealand white 
rabbits which were chosen as a model on account of 
being most susceptible and sensitive to present 
cardiovascular diseases, quite similar to and with the 
involvement of same molecular mechanisms as in 
humans, through high cholesterol diet.4Tocotrienols 
have achieved a substantial momentum during the last 
few years owing to their powerful antioxidant and 
anti-inflammatory properties and δ-tocotrienol was 
found to be the most potent isoform. Cholesterol 
lowering properties of tocotrienols have been reported 
by some researchers but with conflicting results.5,6 But, 
tocotrienol rich fraction of either rice bran oil or palm 
oil was used.  Rice bran oil is a natural source of 
tocotrienols but it contains 50% tocopherols and 50% 
tocotrienols.7 Crude palm oil contains 70% tocotrienols 
and 25% tocopherols.4 Annatto (Bixa orellana L.) seeds 
extract is the only source containing 100% 
tocotrienols.8 Current state of knowledge warrants that 
tocopherols interfere with the absorption of 
tocotrienols.9 Results from supplements containing 
pure tocotrienols may have more promising results.  
Substantial beneficial response to tocotrienols also 
depends on fed or fasted conditions. The fed state 
increased the onset as well as extent of absorption of 
tocotrienols by greater than two folds.10Tocotrienols 
alter the metabolism of steroids and promote their 
clearance from intestine and are speculated to 
stimulate cholesterol catabolism.11,12  
Conclusion 
Human trials should be considered for final 
elucidation of tocotrienols as cholesterol lowering 
agents. 
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